RE:The Cost of Selling Something "Why did Bioasis end up selling everything for almost nothing anyway, with over 75% of Biodexa going into private hands?"
25% of the bioteh industry was trading below the value of the cash on the balance sheet. The science had a NEGATIVE value. How many more would have had a NEGATIVE value if the industry was preclinical, had BTI's debt, had BTI's trackrecord over the last decade, had BTI's partners under a code of silence, were listed on the TSV.V where they traded by appointment, and had to pay Ladenberg Thalmann to help with strategic alternatives?